Browsing Tag
Purchase
2 posts
Why CGTX stock could draw attention after FDA alignment on DLB psychosis
Cognition Therapeutics’ FDA alignment gives zervimesine a clearer DLB psychosis path, sharpening CGTX’s dementia drug development and stock story.
PepsiCo closes $1.95bn Poppi deal: Can the gut health soda scale globally?
PepsiCo’s $1.95B acquisition of poppi strengthens its wellness drinks strategy—see how this Gen Z soda brand could reshape functional beverages.